A detailed history of Yousif Capital Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Yousif Capital Management, LLC holds 44,273 shares of CYTK stock, worth $2.31 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
44,273
Previous 49,096 9.82%
Holding current value
$2.31 Million
Previous $2.66 Million 12.14%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$51.22 - $60.16 $247,034 - $290,151
-4,823 Reduced 9.82%
44,273 $2.34 Million
Q2 2024

Jul 31, 2024

BUY
$47.86 - $75.05 $175,311 - $274,908
3,663 Added 8.06%
49,096 $2.66 Million
Q1 2024

Apr 26, 2024

SELL
$63.75 - $108.06 $222,870 - $377,777
-3,496 Reduced 7.15%
45,433 $3.19 Million
Q4 2023

Feb 01, 2024

SELL
$26.88 - $83.49 $40,158 - $124,734
-1,494 Reduced 2.96%
48,929 $4.09 Million
Q3 2023

Oct 30, 2023

SELL
$29.46 - $36.61 $84,756 - $105,326
-2,877 Reduced 5.4%
50,423 $1.49 Million
Q2 2023

Aug 02, 2023

SELL
$32.62 - $40.75 $84,420 - $105,461
-2,588 Reduced 4.63%
53,300 $1.74 Million
Q1 2023

May 02, 2023

SELL
$33.36 - $45.71 $231,852 - $317,684
-6,950 Reduced 11.06%
55,888 $1.97 Million
Q4 2022

Jan 09, 2023

SELL
$35.77 - $51.11 $470,196 - $671,840
-13,145 Reduced 17.3%
62,838 $0
Q3 2022

Nov 04, 2022

BUY
$38.54 - $54.52 $220,371 - $311,745
5,718 Added 8.14%
75,983 $3.68 Million
Q2 2022

Aug 01, 2022

SELL
$33.93 - $48.92 $169,141 - $243,866
-4,985 Reduced 6.62%
70,265 $2.76 Million
Q1 2022

May 12, 2022

BUY
$29.74 - $46.0 $26,914 - $41,630
905 Added 1.22%
75,250 $2.77 Million
Q4 2021

Jan 31, 2022

BUY
$34.35 - $46.38 $2.55 Million - $3.45 Million
74,345 New
74,345 $3.39 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.92B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.